Community HIV clinicians’ perceptions about HIV cure-related research in the Northwestern United States

References

• Deeks S, Lewin S, Havlir D. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–1533.
   PubMed Web of Science ®Google Scholar
• Bloch M, John M, Smith D, Rasmussen T, Wright E. Managing HIV-associated inflammation and ageing in the era of modern ART. HIV Med. 2020;21(Suppl 3):2–16.
   Google Scholar
• Ndung'u T, McCune JM, Deeks SG. Why and where an HIV cure is needed and how it might be achieved. Nature 2019;576(7787):397–405.
   PubMed Web of Science ®Google Scholar
• Barr L, Jefferys R. A landscape analysis of HIV cure-related clinical research in 2019. J Virus Erad. 2020;6(4):100010.
   PubMed Web of Science ®Google Scholar
• AVAC. Global Investment in HIV Cure Research and Development. 2021.
   Google Scholar
• TAG. Research toward a Cure Trials. 2021. Available: http://www.treatmentactiongroup.org/cure/trials
   Google Scholar
• Deeks SG, Lewin SR, Ross AL, International AIDS Society Towards a Cure Working Group, et al. International AIDS society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016;22(8):839–850.
   PubMed Web of Science ®Google Scholar
• Grossman CI, Ross AL, Auerbach JD, International AIDS Society (IAS) ‘Towards an HIV Cure’ initiative, et al. Towards multidisciplinary HIV-cure research: integrating social science with biomedical research. Trends Microbiol. 2016;24(1):5–11.
   PubMed Web of Science ®Google Scholar
• Julg B, Dee L, Ananworanich J, et al. Recommendations for analytical treatment interruptions in HIV research trials. Lancet HIV. 2019;6(4):e259–e268.
   PubMed Web of Science ®Google Scholar
• Garner SA, Rennie S, Ananworanich J, et al. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad. 2017;3(2):82–84.
   PubMed Web of Science ®Google Scholar
• Dubé K, Evans D, Dee L, et al. “We need to deploy them very thoughtfully and carefully: perceptions of analytical treatment interruptions in HIV cure research in the United States.” AIDS Res Hum Retroviruses. 2018;34(1):67–79.
   PubMed Web of Science ®Google Scholar
• Eyal N, Holtzman LG, Deeks SG. Ethical issues in HIV remission trials. Curr Opin HIV AIDS. 2018;13(5):422–427.
   PubMed Web of Science ®Google Scholar
• Peluso MJ, Dee L, Shao S, et al. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-Cov-2 pandemic: a collaborative approach. Clin Infect Dis. 2020;ciaa1260.
   Web of Science ®Google Scholar
• Dubé K, Kanazawa JT, Dee L, et al. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pr. 2021;1–17.
   Google Scholar
• Dresser R. First-in-human HIV-remission studies: reducing and justifying risk. J Med Ethics. 2017;43(2):78–81.
   PubMed Web of Science ®Google Scholar
• Dubé K, Henderson GE, Margolis DM. Framing expectations in early HIV cure research. Trends Microbiol. 2014;22(10):547–549.
   PubMed Web of Science ®Google Scholar
• Dubé K, Simoni J, Louella M, et al. Acceptability of cell and gene therapy for curing HIV infection among people living with HIV in the Northwestern United States: a qualitative study. AIDS Res Hum Retroviruses. 2019;35(7):649–659.
   PubMed Web of Science ®Google Scholar
• Moodley K, Rossouw T, Staunton C, Colvin CJ. Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa. BMC Med Ethics. 2016;17(1):26.
   PubMedGoogle Scholar
• Protière C, Fressard L, Mora M, the APSEC Study Group, et al. Characterization of physicians that might be reluctant to propose HIV cure-related clinical trials with treatment interruption to their patients? The ANRS-APSEC study. Vaccines 2020;8(2):334.
   Web of Science ®Google Scholar
• Rich ZC, Liu C, Ma Q, et al. Physician perceptions of HIV cure in China: a mixed methods review and implications for HIV cure research. Asian Pacific J Trop Dis. 2015;5(9):687–690.
   Google Scholar
• Wozniak RJ, Cerqueira NB, Dantas MCS, et al. Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil. BMJ Open. 2020;10(11):e040092.
   Web of Science ®Google Scholar
• Préau M, Doumergue M, Protière C, et al. Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV. AIDS Care. 2018;30(7):914–920.
   PubMed Web of Science ®Google Scholar
• Protière C, Preau M, Carrieri P, Lambotte O, Spire B, Suzan-Monti M. Importance of the patient-physician interaction in assessing acceptability of HIV cure trials. HIV Med. 2018;19(4):e56–e57.
   Web of Science ®Google Scholar
• Lau JSY, Smith MZ, Allan B, et al. Perspectives on analytical treatment interruptions in people living with HIV and their health care providers in the landscape of HIV cure-focused studies. AIDS Res Hum Retroviruses. 2019;1–8.
   Web of Science ®Google Scholar
• Protière C, Arnold M, Fiorentino M, et al. Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment. J Int AIDS Soc. 2020;23:1–9.
   Web of Science ®Google Scholar
• Moodley K, Staunton C, de Roubaix M, Cotton M. HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives. AIDS Care. 2016;28(4):524–524.
   PubMed Web of Science ®Google Scholar
• Chu CE, Wu F, He X, et al. Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. AIDS Res Hum Retroviruses. 2015;31(1):78–84.
   Web of Science ®Google Scholar
• Walsh E, Sheridan A. Factors affecting patient participation in clinical trials in Ireland: a narrative review. Contemp Clin Trials Commun. 2016;3:23–31.
   PubMed Web of Science ®Google Scholar
• Dubé K, Ramirez C, Handibode J, et al. Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research. J Virus Erad. 2015;1:e14–20.
   Google Scholar
• Sahay S, Mehendale S, Sane S, et al. Correlates of HIV vaccine trial participation: an indian perspective. Vacccine 2005;23(11):1351–1358.
   PubMed Web of Science ®Google Scholar
• Houlihan RH, Kennedy MH, Kulesher RR, et al. Identification of accrual barriers onto breast cancer prevention clinical trials: a case-control study. Cancer 2010;116(15):3569–3576.
   Web of Science ®Google Scholar
• Brown D, Topcu M. Willingness to participate in clinical treatment research among older African Americans and whites. Gerontologist. 2003;43(1):62–72.
   PubMed Web of Science ®Google Scholar
• McMahon V, Matthews S, Capper H, Chudleigh J, McLachlan C. Understanding decision and enabling factors influencing clinical trial participation in Australia: a view point. Asian Pac J Cancer Prev. 2011;12:153–156.
   Google Scholar
• Sabesan S, Burgher B, Buettner P, et al. Attitudes, knowledge, and barriers to participation in cancer clinical trials among rural and remote patients. Asia Pac J Clin Oncol. 2011;7(1):27–33.
   Web of Science ®Google Scholar
• Dubé K, Evans D, Sylla L, et al. Willingness to participate in HIV cure research: survey results from 400 people living with HIV in the United States. J Virus Erad. 2017;3(1):40–50.
   Web of Science ®Google Scholar
• Dubé K, Eskaf S, Evans D, et al. The dose response: perceptions of people living with HIV in the United States on alternatives to oral daily antiretroviral therapy. AIDS Res Hum Retroviruses. 2019.
   Web of Science ®Google Scholar
• Dubé K, Taylor J, Sylla L, et al. “Well, it’s the risk of the unknown … Right?”: a qualitative study of perceived risks and benefits of HIV cure research in the United States. PLoS ONE. 2017;12(1):e0170112–23.
   PubMed Web of Science ®Google Scholar
• Sylla L, Evans D, Taylor J, et al. If we build it, will they come? Perceptions of HIV cure-related research by people living with HIV in four U.S. cities: a qualitative focus group study. AIDS Res Hum Retroviruses. 2018;34(1):56–66.
   PubMed Web of Science ®Google Scholar
• Cresswell J. Research design. Qualitative, Quantitative, and Mixed Methods Approaches. 4th ed. Thousand Oaks: Sage Publications; 2013.
   Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
   Web of Science ®Google Scholar
• Ananworanich J, Dubé K, Chomont N. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? Curr Opin HIV AIDS. 2015;10(1):18–28.
   PubMed Web of Science ®Google Scholar
• Sullivan LM, Stein MD, Savetsky JB, Samet JH. The doctor-patient relationship and HIV-infected patients’ satisfaction with primary care physicians. J Gen Intern Med. 2000;15(7):462–469.
   PubMed Web of Science ®Google Scholar
• Kumar R, Korthuis PT, Saha S, et al. Decision-making role preferences among patients with HIV: associations with patient and provider characteristics and communication behaviors. J Gen Intern Med. 2010;25(6):517–523.
   PubMed Web of Science ®Google Scholar
• Protière C, Spire B, Mora M, et al. Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. findings from a multicentre French survey using Q methodology (ANRS-ASPECT). PLoS One. 2017;12(11):e0187489.
   PubMed Web of Science ®Google Scholar
• Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies. J Acquir Immune Defic Syndr. 2016;71(2):181–188.
   PubMed Web of Science ®Google Scholar
• Dubé K, Kanazawa JT, Campbell C, et al. Considerations for increasing racial, ethnic, gender and sexual diversity in HIV cure-related research with analytical treatment interruptions: a qualitative inquiry. AIDS Res Hum Retroviruses. 2021;
   Web of Science ®Google Scholar
• Barr L, Jeffreys R. Treatment action group HIV cure landscape analysis. Pre-CROI Community Cure Workshop. Seattle, WA; 2019.
   Google Scholar
• INSIGHT Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.
   Web of Science ®Google Scholar
• Eholié SP, Badje A, Kouame GM, et al. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question. AIDS Res Ther. 2016;13:27.
   Web of Science ®Google Scholar
• Pentz RD, White M, Harvey RD, et al. Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 Trials. Cancer 2012;118(18):4571–4578.
   PubMed Web of Science ®Google Scholar